Last reviewed · How we verify
Insulatard
Insulatard is a Small molecule drug developed by University of Aarhus. It is currently FDA-approved.
At a glance
| Generic name | Insulatard |
|---|---|
| Sponsor | University of Aarhus |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Impact on Birth Weight of Two Therapeutic Strategies (Insulin Therapy From the Beginning of Pregnancy vs. Insulin Therapy Initiated According to Fetal Growth Evaluated by Ultrasonography Measurements) in Pregnant Women With Monogenic Diabetes (NA)
- DECIDE: A Comparative Effectiveness Trial of Metformin Versus Insulin for the Treatment of Gestational Diabetes (PHASE4)
- Comparison of the Efficacy and Safety of GLARGEN® Versus NPH Insulin in Diabetic Tunisian Patients. (PHASE4)
- Comparison of Thrice-Daily Premixed Human Insulin with Basal-Bolus Therapy Among Patients with Poorly Controlled Type 2 Diabetes Mellitus (PHASE4)
- Comparative Efficacy of a Two Daily Mixed Insulin Injection Versus a Basal-bolus Scheme With Human Insulin (PHASE4)
- RCT Glargine vs NPH for Treatment of DM in Pregnancy (PHASE3)
- Effect of Insulin Detemir on Blood Glucose Control in Subjects With Type 2 Diabetes (PHASE3)
- The Effect of Exercise on Blood Glucose Levels in Patients With Type 1 Diabetes: A Comparison of 3 Long-acting Insulins (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Insulatard CI brief — competitive landscape report
- Insulatard updates RSS · CI watch RSS
- University of Aarhus portfolio CI
Frequently asked questions about Insulatard
What is Insulatard?
Insulatard is a Small molecule drug developed by University of Aarhus.
Who makes Insulatard?
Insulatard is developed and marketed by University of Aarhus (see full University of Aarhus pipeline at /company/university-of-aarhus).
What development phase is Insulatard in?
Insulatard is FDA-approved (marketed).
Related
- Manufacturer: University of Aarhus — full pipeline
- Therapeutic area: All drugs in Other
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing